Glutathione Side Effects: Oral Is Mild, Injectable Is Not

By Erin Rose · Published August 21, 2026 · Reviewed against primary sources · Methodology · About Us

Educational overview — not medical advice. This page does not endorse IV or injectable glutathione for any use. Glutathione has no established RDA or upper limit, and no pregnancy/breastfeeding safety data exists at any dose or route. This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Looking for a tested product? See our best glutathione ranked by cost per actual mg, which links this safety detail too →

Oral glutathione: mild, and here's the mechanistic reason why

If you're taking a glutathione capsule, the side-effect profile is genuinely unremarkable. The trials behind this site's dosage guidance — Richie 2015's 6-month RCT at 250-1000mg/day, and the smaller 4-12 week skin-lightening trials at 250-500mg/day — report no serious adverse events. Occasional mild GI complaints (bloating, cramping) show up in anecdotal reports, but no oral trial in this evidence set quantifies a specific rate.

There's a real, unglamorous reason oral glutathione tends to be so well tolerated, and it's tied directly to the same absorption story covered on our absorption & skin-whitening page: a classic pharmacokinetic study found that oral glutathione's systemic availability is negligible at doses up to 3 grams, because intestinal and hepatic enzymes break it down before it reaches circulation intact (Witschi 1992). That doesn't mean oral glutathione does nothing — Richie 2015's later, longer trial found sustained daily dosing over months does measurably raise your body's own glutathione stores. But at any single dose, relatively little of what you swallow is circulating intact, which is a large part of why there's relatively little of it around to cause a reaction.

IV and injectable glutathione: what regulators have actually said

Two separate national regulators have flagged injectable glutathione, for two related but distinct reasons, and both are worth knowing plainly.

The Philippine FDA issued a public advisory warning specifically against injectable glutathione for skin lightening. Its stated concerns: no published clinical trials support the injectable route's efficacy for skin lightening, injectable glutathione is not approved for that indication (it is approved there only as an adjunct in cisplatin chemotherapy), and reported risks include toxic effects on the liver, kidneys, and nervous system, plus the possibility of Stevens-Johnson syndrome, a rare and serious skin/mucous-membrane reaction. A review of the skin-whitening literature makes the same point about the evidence gap: no RCT has established IV glutathione's efficacy for lightening skin, and off-label IV use has drawn a public safety warning after adverse effects (Sonthalia 2016).

The harm isn't hypothetical. A 2025 narrative review summarizing a placebo-controlled trial of injectable glutathione for skin lightening reported that 32% of participants developed deranged liver function tests and one participant had anaphylaxis, severe enough that some patients had to stop treatment before the trial ended (Alzahrani 2025). Separately, a documented case series describes seven patients who developed acute systemic inflammatory symptoms — high fever, severe low blood pressure, vomiting, and days-long hospitalization — within two hours of receiving IV glutathione infusions that testing later confirmed were contaminated with bacterial endotoxin far above accepted safety limits (Johnstone 2018). Those particular patients were being treated for a different condition, not skin lightening, but the underlying failure mode is the same one regulators keep flagging: injectable glutathione is often compounded from dietary-supplement-grade powder that was never manufactured or tested to injectable sterility standards. The U.S. FDA has separately and directly warned compounding pharmacies against this practice, after real patients receiving compounded glutathione injections suffered adverse reactions tied to endotoxin contamination in the powder used.

None of the oral or topical evidence discussed on our absorption & skin-whitening page should be read as reassurance about the IV route. They are different products with a different, and considerably worse-documented, risk profile.

Inhaled glutathione and asthma: a specific, real caution

Nebulized or inhaled glutathione shows up in some alternative-lung-health protocols, and there's a specific reason to be cautious if you have asthma. A placebo-controlled crossover trial in eight people with mild asthma found that a single nebulized 600mg glutathione dose caused measurable bronchoconstriction — FEV1 (a standard lung-function measurement) fell 19% versus 1% with placebo, and airway resistance rose 61% versus 17% with placebo, both statistically significant differences. Seven of the eight patients developed cough or breathlessness (Marrades 1997). The likely mechanism is sulfite formation in the nebulized solution, and pre-treatment with a bronchodilator blocked the effect — but the practical takeaway is straightforward: inhaled glutathione is not something to self-administer if you have asthma without a doctor involved.

Zinc status and other long-term unknowns

Two honest gaps are worth naming rather than glossing over. First, some clinical sources caution that glutathione and zinc share metabolic pathways and that sustained, high-dose glutathione supplementation could plausibly affect zinc status over time — but no controlled human trial in this evidence set actually measured zinc levels before and after glutathione supplementation, so this stays a plausible, unproven caution rather than a documented effect. If you take glutathione at a meaningful dose for months at a time, mentioning it to a doctor alongside your usual bloodwork is reasonable; treating it as a confirmed side effect is not.

Second, no trial in this evidence set has tested glutathione safety beyond 6 months. Richie 2015, the longest oral trial behind this site's dosing guidance, ran 6 months. That is not the same claim as "long-term use is dangerous" — it is the claim that nobody has actually looked, which matters if you're planning to take it indefinitely. There is also no safety data at all for pregnancy or breastfeeding, at any dose or route, and no established RDA or upper limit against which to judge a "high" dose in the first place.

Glutathione side effects at a glance

Compare Glutathione Products by Cost Per Actual Mg

If you're ready to buy, here's how the glutathione products we track and verify compare on cost per actual mg of reduced glutathione.

Frequently asked questions

Related guides

• Glutathione Benefits — what the evidence actually supports, graded by claim
• Absorption & Skin-Whitening, in Full — the complete oral-vs-IV evidence breakdown
• Glutathione Dosage Guide — the 250-1000mg/day range trials actually used
• Glutathione for Liver & Oxidative Stress — proven mechanism vs. marketing
• Best Glutathione — ranked by cost per actual mg, not absorption claims
• NAC for Liver & Glutathione — the cheaper, better-evidenced oral route to raising glutathione
• All Glutathione Guides

Sources